Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05821_nanopub.RAT7su1V6YJUdIguCyG_krDMD1bZVoQ1-Hx0UFBNJoIiE#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05821 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05821 label "DP-VPA [drugbank:DB05821]" assertion.
- drugbank:DB05821 seeAlso DB05821 assertion.
- drugbank:DB05821 description "DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure frequency." assertion.
- drugbank:DB05821 identifier "drugbank:DB05821" assertion.
- drugbank:DB05821 title "DP-VPA" assertion.
- drugbank:DB05821 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05821 drugbank_vocabulary:drugbank-id "DB05821" assertion.
- drugbank:DB05821 bio2rdf_vocabulary:x-identifiers.org DB05821 assertion.
- drugbank:DB05821 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05821" assertion.
- drugbank:DB05821 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05821 bio2rdf_vocabulary:identifier "DB05821" assertion.